Trodelvy dosing is 10 mg/kg IV on days 1 and 8 of 21-day cycles, continued until progression or unacceptable toxicity; pembrolizumab schedules follow prescriber determination. Safety requires ...

Because Keytruda is an intravenous infusion and not a medicine that a person can self-administer, Medicare Part B will help pay for the drug. Part B covers medical services, including doctor’s visits, ...

The push to bring a subcutaneous version of Keytruda to market comes as Merck prepares for loss of exclusivity. (Photo by Kena Betancur/Getty Images) Merck has talked up the value of its subcutaneous ...

The U.S. Food and Drug Administration (FDA) has approved a new way to give pembrolizumab (brand name: Keytruda), one of the most widely used immunotherapy treatments for cancer. For the first time, ...

Both Opdivo and Keytruda come as liquid solutions. The two drugs are given as an intravenous (IV) infusion, which is an injection into your vein given over a period of time. Infusions for both Opdivo ...

The approvals are based on data from the pivotal Phase III LITESPARK-022 trial, which enrolled 1,841 patients.

For 2029, a federal rule proposes closing a "loophole" that protects medicines transitioning from intravenous administration ...

In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Merck & Co., Inc. is placed fourth among them. Merck & Co., Inc. (NYSE:MRK), a global ...